v3.25.2
Segment Information - Schedule of Consolidated Statements of Operations (Details) - Operating Segments [Member] - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Dec. 31, 2023
Revenue        
Total Clinics level revenue $ 3,639,209 $ 4,831,567    
Operating expenses        
General and administrative expenses 709,376 1,089,578 $ 2,688,157 $ 3,056,702
Total Clinics level expenses 3,634,063 4,814,832 15,987,718 16,178,180
Adjusted Clinics EBITDA 5,146 16,735 604,391 497,213
Reconciliation of Adjusted Clinics EBITDA to net income        
Depreciation and amortization 275,392 367,197 1,308,619 1,252,539
Interest expense 407,728 559,289 3,098,237 2,538,710
Other income (expenses) (2) 4,768 (1,134)
Corporate general and administrative 1,737,062 1,783,765 8,733,195 6,419,585
Debt extinguishment loss 728,278 16,105
Net Income (2,415,036) (3,421,792) (14,264,261) (14,792,907)
Service revenue [Member]        
Revenue        
Total Clinics level revenue 2,741,029 3,545,599 12,188,526 11,879,934
Product revenue [Member]        
Revenue        
Total Clinics level revenue 898,180 1,285,968 4,403,583 4,795,459
Cost of service revenue [Member]        
Operating expenses        
Cost of product revenue (exclusive of depreciation and amortization, shown separately below) 2,139,278 2,709,147 9,736,282 9,700,963
Cost of product revenue [Member]        
Operating expenses        
Cost of product revenue (exclusive of depreciation and amortization, shown separately below) $ 785,409 $ 1,016,107 $ 3,563,279 $ 3,420,515